OR WAIT null SECS
Is ensuring integrity within the clinical trials enterprise, as some claim, beyond the reach of industry?
In his July Clinical Trials Insight column, Kenneth Getz examines the recent harsh criticisms by academia aimed at industry research. Although for years academia has considered itself above industry, as of late some academics are taking their bias to the extreme, “calling for industry to have no involvement in clinical research,” according to Getz. They believe that the problems within the enterprise, such as conflicts of interest or unethical practices, are isolated to industry and suggest that only academic-based professionals can ensure integrity.
Check out how Getz responds to this view in “Are Academia and NIH Bastions of Integrity” and then let us know how you feel about it in an email to email@example.com.
Responses and discussion regarding this topic will appear in a future blog post on this Web site.